门诊森田疗法辅助抑郁症药物治疗的疗效

An Efficacy Study on Morita Therapy Combined with Drug Treatment in Patients with Depression.

目的探讨门诊森田疗法辅助抑郁症药物治疗的近期和远期疗效。方法选择门诊抑郁症患者60例,随机分成研究组和对照组各30例,研究组患者接受药物治疗联合门诊森田疗法,而对照组只接受单独的药物治疗,观察8周,再随访8个月。在治疗前、治疗8周末及随访8个月时分别对两组患者实施汉密尔顿抑郁量表(HAMD)和健康状况调查问卷(SF-36),以评价门诊森田疗法辅助抑郁症药物治疗的近期和远期疗效。结果①治疗8周末及随访8个月时研究组的汉密尔顿量表得分均低于对照组,差异有统计学意义(t=4.65,5.76;P<0.01);②健康状况调查问卷得分:治疗8周末,研究组的生理功能、社会功能、躯体疼痛、精神健康4个因子得分高于对照组,差异有统计学意义(t=2.31,2.51,256,P<0.05或t=2.99,P<0.01);随访8个月时,生理功能、生理职能、情感职能、躯体疼痛、活力、精神健康、总体健康7个因子得分高于对照组,差异有统计学意义(t=3.41,4.18,2.99,3.61,3.43,5.73,3.02,P<0.01)。结论门诊森田疗法辅助抑郁症药物治疗的近期和远期疗效均较单纯药物的疗效好,值得临床进一步推广。

Objective To evaluate the short-term and long-term efficacy of Morita therapy combined with drug treatment in patients with depression.Methods A total of 60 outpatients with depression were randomly assigned to study group and control group,30 cases each.The study group received drug treatment and Morita therapy,while the control group received drug treatment only for 8 weeks,then followed up 8 months.Before and after 8-week treatment and follow-up 8-month,two groups were assessed with the Hamilton Depression Scale（HAMD） and Outcomes Study Short-form 36（SF-36）.Results ① After 8 weeks and follow-up 8 months,the scores of HAMD were lower in study group than in control groups（t=4.65,5.76;P0.01）.②After 8 weeks,the scores of physical functioning,social functioning,bodily pain and mental health in SF-36 of the study group were higher than those of the control group（t=2.31,2.51,2.56;P0.05 or t=2.99,P0.01）;Follow-up 8 months,the scores of physical functioning,role-physical,role-emotional,bodily pain,vitality,mental health,and general health in SF-36 of the study group were higher than those of the control group（t=3.41,4.18,2.99,3.61,3.43,5.73,3.02;P0.01）.Conclusion The short-term and the long-term efficacy of Morita therapy combined with drug treatment are better than mono-drug treatment in patients with depression.